Icatibant Acetate
Icatibant Acetate is a selective bradykinin B2 receptor antagonist. It is applied in hereditary angioedema research and utilized in both in vitro binding assays and in vivo models to study bradykinin-mediated pathways.
Product Specifications
Product Name Alternative
Ulcerative, inhibit, Icatibant, Icatibant Acetate, Inhibitor, HOE 140, HOE140, HOE-140, angiotensin, bradykinin B2, bradykinin B2 receptor, Bradykinin Receptor, BradykininReceptor, colitis
Field of Research
Pharmacology & Drug Discovery
Purity
98.00% (May vary between batches)
Solubility
H2O:100 mg/mL (73.28 mM) ; DMSO:122.5 mg/mL (89.77 mM)
Molecular Weight
1364.57
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15089425 1 Vial
Lentiviral human KCNE1 shRNA (UAS) - Lentiviral human KCNE1 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details MBS6328331-01 0.2 mL
OR2AK2, CT (OR2AK2, OR2AK1P, Olfactory receptor 2AK2, Olfactory receptor 2AK1, Olfactory receptor OR1-47) (Azide free) (HRP)
Sign In for Pricing
View Details MBS6328331-02 5x 0.2 mL
OR2AK2, CT (OR2AK2, OR2AK1P, Olfactory receptor 2AK2, Olfactory receptor 2AK1, Olfactory receptor OR1-47) (Azide free) (HRP)
Sign In for Pricing
View Details